Medpace Holdings, Inc.·4

Feb 26, 4:18 PM ET

Carley Brian T 4

4 · Medpace Holdings, Inc. · Filed Feb 26, 2025

Insider Transaction Report

Form 4
Period: 2025-02-24
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-24$42.62/sh+8,127$346,37330,035 total
  • Sale

    Common Stock

    2025-02-24$345.59/sh4,003$1,383,39726,032 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-02-248,1270 total
    Exercise: $42.62Exp: 2025-05-18Common Stock (8,127 underlying)
Footnotes (2)
  • [F1]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $344.798 to $346.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
  • [F2]The option vested in full on May 16, 2019.

Documents

1 file
  • 4
    wk-form4_1740604724.xmlPrimary

    FORM 4